Kyu-Sung Lee, Ph.D
Samsung Medical Center
18
18
18
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+14 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (18)
Showing 10 of 18 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Emily Lukacz, MD
University of California, San Diego
Shared therapeutic areas:
Rose Khavari, MD
The Methodist Hospital Research Institute
Shared therapeutic areas:
Ho-Hsiung Lin, PhD
National Taiwan University Hospital
Shared therapeutic areas:
Chi Fai Ng, MD
Chinese University of Hong Kong
Shared therapeutic areas:
Karen Sepucha, PhD
Massachusetts General Hospital
Shared therapeutic areas:
Hann-Chorng Kuo, M.D.
Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University
Shared therapeutic areas:
David Sheyn, MD
University Hospitals Cleveland Medical Center
Shared therapeutic areas:
Zhishun Liu
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Shared therapeutic areas:
Dorota Sys, PhD
Centre of Postgraduate Medical Education
Shared therapeutic areas:
Project Leader, Development Planning
Ono Pharmaceutical Co., Ltd.
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (18)
Showing 18 of 18 trials
Efficacy and Safety of Alfuzosin for the Treatment of Voiding Dysfunction in Female
Exploring Predictors of Symptoms Relapse After Discontinuation of Treatment in Overactive Bladder (OAB) Patients
Effect of Dutasteride on Bladder Wall Hypertrophy in Patients With Benign Prostatic Obstruction
Assessment of Patient-reported Goal Attainment in the Treatment of Female Overactive Bladder
Evaluation of Symptom-specific Goal Achievement
Microorganism in Overactive Bladder Patients
Efficacy and Safety of Selective Serotonin Reuptake Inhibitor (SSRI) in Overactive Bladder Patients
Desmopressin in the Treatment of Mixed Nocturia With Nocturnal Polyuria and Low Nocturnal Bladder Capacity
Urinary Urgency Outcomes Following Propiverine Treatment for an Overactive Bladder
Efficacy and Safety of Extracorporeal Biofeedback
Efficacy of Electromagnetic Stimulation Therapy for Chronic Prostatitis and Chronic Pelvic Pain Syndrome
Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH)
Clinical Evaluation of the Needleless® Sling
Comparison Between Alpha Blocker Monotherapy and 5ARI Monotherapy Following Combination Therapy in Benign Prostatic Hyperplasia (BPH)
Urinary Urinary Nerve Growth Factor (NGF) as a Biomarker for Mixed Urinary Incontinence
Urinary Nerve Growth Factor (NGF), Prostaglandin E2 (PGE2)and Adenosine Triphosphate (ATP): Potential Biomarkers in Overactive Bladder Patients
The Comparison of Efficacy Between Electromagnetic Stimulation Therapy and Electromagnetic Stimulation Therapy With Extracorporeal Biofeedback
Prospective Study for Patient Perception of Treatment Satisfaction After Switching to Mirabegron in Patients With Overactive Bladder Who Were Unsatisfied With Efficacy of Antimuscarinic Therapy or Adverse Event.
All 18 trials loaded